Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct;88(4):888-96.
doi: 10.1038/ki.2015.199. Epub 2015 Jul 22.

Biomarkers of Rapid Chronic Kidney Disease Progression in Type 2 Diabetes


Biomarkers of Rapid Chronic Kidney Disease Progression in Type 2 Diabetes

Helen C Looker et al. Kidney Int. .


Here we evaluated the performance of a large set of serum biomarkers for the prediction of rapid progression of chronic kidney disease (CKD) in patients with type 2 diabetes. We used a case-control design nested within a prospective cohort of patients with baseline eGFR 30-60 ml/min per 1.73 m(2). Within a 3.5-year period of Go-DARTS study patients, 154 had over a 40% eGFR decline and 153 controls maintained over 95% of baseline eGFR. A total of 207 serum biomarkers were measured and logistic regression was used with forward selection to choose a subset that were maximized on top of clinical variables including age, gender, hemoglobin A1c, eGFR, and albuminuria. Nested cross-validation determined the best number of biomarkers to retain and evaluate for predictive performance. Ultimately, 30 biomarkers showed significant associations with rapid progression and adjusted for clinical characteristics. A panel of 14 biomarkers increased the area under the ROC curve from 0.706 (clinical data alone) to 0.868. Biomarkers selected included fibroblast growth factor-21, the symmetric to asymmetric dimethylarginine ratio, β2-microglobulin, C16-acylcarnitine, and kidney injury molecule-1. Use of more extensive clinical data including prebaseline eGFR slope improved prediction but to a lesser extent than biomarkers (area under the ROC curve of 0.793). Thus we identified several novel associations of biomarkers with CKD progression and the utility of a small panel of biomarkers to improve prediction.

Similar articles

See all similar articles

Cited by 38 articles

See all "Cited by" articles


    1. Am J Nephrol. 2011;34(3):268-80 - PubMed
    1. Kidney Int. 2014 May;85(5):1214-24 - PubMed
    1. Clin Res Cardiol. 2013 Mar;102(3):193-202 - PubMed
    1. Metabolism. 2010 Nov;59(11):1656-62 - PubMed
    1. Endocrinology. 2013 Sep;154(9):3366-76 - PubMed

Publication types

MeSH terms